PLEKHM2 inhibitors are a class of chemical compounds that have garnered significant attention in the field of molecular biology and cellular research. PLEKHM2, short for Pleckstrin homology domain-containing family M member 2, is a multifunctional protein that plays a crucial role in intracellular trafficking and autophagy processes within cells. These inhibitors are specifically designed to target and impede the function of PLEKHM2, thereby providing researchers with a valuable tool to dissect the intricate mechanisms governing vesicular transport and autophagy.
At the molecular level, PLEKHM2 inhibitors are typically small molecules or compounds that interact with specific regions of the PLEKHM2 protein, disrupting its normal functions. PLEKHM2 itself contains several domains, including a Pleckstrin homology (PH) domain, a RAB7-binding domain, and a coiled-coil domain, all of which are essential for its cellular functions. PLEKHM2 inhibitors are designed to interfere with these domains, either by binding to them directly or by modulating their activity. By doing so, these inhibitors can hinder the interactions of PLEKHM2 with other cellular components, leading to a disruption in vesicle trafficking and autophagy pathways. Researchers use PLEKHM2 inhibitors as powerful tools to unravel the intricacies of these processes, shedding light on fundamental cellular mechanisms and implications in various physiological and pathological conditions.
In summary, PLEKHM2 inhibitors represent a significant class of chemical compounds utilized in cellular and molecular research to investigate the role of PLEKHM2 in intracellular transport and autophagy. These inhibitors function by disrupting specific domains within the PLEKHM2 protein, ultimately influencing cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Binds to the V-ATPase complex, inhibiting lysosomal acidification and autophagy. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $275.00 $928.00 $1543.00 | 14 | |
Acts as a cysteine protease inhibitor, potentially disrupting Plekhm2-dependent processes. | ||||||
NH125 | 278603-08-0 | sc-203037 | 5 mg | $187.00 | 1 | |
Inhibits nucleoside diphosphate kinase activity, potentially affecting Plekhm2-mediated signaling. | ||||||
Reversine | 656820-32-5 | sc-203236 | 5 mg | $217.00 | 13 | |
Suppresses phosphatidylinositol 3-kinase (PI3K) activity, potentially impacting Plekhm2 signaling. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $140.00 $500.00 | 2 | |
Inhibits cholesterol transport, potentially disrupting Plekhm2's role in cholesterol homeostasis. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
Inhibits the autophagy kinase Vps34, which may indirectly impact Plekhm2-mediated autophagy processes. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $215.00 $622.00 | 5 | |
Blocks Ras protein prenylation, potentially affecting Ras-mediated pathways involving Plekhm2. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $165.00 | ||
Suppresses USP10 and USP13 deubiquitinase activity, potentially affecting Plekhm2-associated processes. | ||||||
PIK-75, hydrochloride | 372196-77-5 | sc-296089 sc-296089A | 1 mg 5 mg | $28.00 $122.00 | ||
Selectively inhibits the PI3Kα isoform, impacting PI3K signaling pathways that Plekhm2 may participate in. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $30.00 $125.00 $445.00 | 45 | |
A p38 MAP kinase inhibitor that could affect Plekhm2 signaling through the p38 pathway. | ||||||